Molecular Data Inc. — key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2020)

¥1.2B

Net Income/Loss (FY2020)

-¥50.3M

Total Assets (FY2020)

$105.0M

Total Equity (FY2020)

-¥27.9M

Cash Flows from Operating Activities (FY2020)

-¥35.9M

Source: Molecular Data Inc. 20-F filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.